Navigation Links
Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
Date:10/4/2007

ANN ARBOR, Mich., Oct. 4 /PRNewswire/ -- Richard D. Dyer, PhD, has been appointed Executive Vice President of Product Development for Velcura Therapeutics, Inc., an early stage biotechnology company developing potentially breakthrough therapies to treat bone diseases.

"We are pleased to add an individual of such high scientific caliber to our management team. Dr. Dyer will oversee our programs to develop second- generation therapies for bone diseases; he also will lead our new initiatives in inflammatory diseases." said Michael W. Long, PhD, president and CEO of Velcura Therapeutics, Inc.

Previous to joining Velcura Therapeutics Dr. Dyer was Vice President of Scientific Affairs and Development at TCH Pharmaceuticals, Inc. Prior to TCH, Dr. Dyer held progressively responsible positions at Pfizer Global Research and Development in Ann Arbor, eventually becoming Director of Inflammation Molecular Sciences and Technology. During his tenure with Pfizer, Dr. Dyer also provided scientific leadership at the distinguished position of Research Fellow in both Biochemistry and Inflammation Pharmacology.

Dr. Dyer completed his bachelors and masters degrees at Purdue University where he was a National Institutes of Health (NIH) Predoctoral Trainee in Environmental Toxicology and Radiation Health. He went on to earn his doctorate degree from the University of Wisconsin where he was both a NIH and Ford Foundation Predoctoral Trainee in Endocrinology/Reproductive Physiology. He was a NIH Postdoctoral Trainee in Endocrinology and Hypertension at the Medical College of Ohio before joining the Pharmaceutical Products Division of Abbott Laboratories in Illinois, where he played a pivotal role in the discovery and development of the FDA approved asthma treatment, Zyflo.

Dr. Dyer is past president and long-standing board member of the Inflammation Research Association. He has served as committee member and assisted in organizing various scientific conference
'/>"/>

SOURCE Velcura Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Former Fiserv exec to enter Business Hall of Fame
2. UW scientist, former WiCell director found stem cell company
3. Kyron appoints former AMA chairman to board
4. Genzyme sues former Bone Care employees
5. Former astronaut a leader in Wisconsin Spaceport
6. New book from former CDC CEO walks readers through innovation
7. Are top performers born or made?
8. Former Thompson lawyer comments on Doyle stem cell executive order
9. Searle spirit lives on in Chicago as alumni celebrate at former home
10. Former NSF director to speak at UW-Madison
11. PDS hires new VP, buys former health club building

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...Newswire-FirstCall/ -- Star Scientific, Inc . (...lans to introduce the CigRx(TM) nutraceutical prod...ceuticals, for worldwide marketing and sales in pa...VTIV). inVentiv Health offers a complete range of...e product lifecycle, in a range of healthcare cate...
(Date:11/4/2009)... Onyx Pharmaceuticals, In...resent at the Credit Suisse 18th Annual Healthcare.... Mountain Time (8:30 a.m. Pacific Time). Interes...ntation on our website at: http://www.onyx-pharm...mmended that listeners log on 15 minutes early in ...
(Date:11/4/2009)...Nov. 4 Emerson Resources, Inc ....y announced that it has formed a strategic partner...ganization that specializes in the agrichemical an...ss development capabilities. The exclusive partner...obert Westbrook, CEO of Bio Research, who is spear...
(Date:11/4/2009)...4 Health Robotics today announced,....v.SOFT Workflow Engine at,the American Society of...ber,6-10 in Las Vegas. With the availability of th...s the first and only company in the world to provi... automated process control and,patient safety in t...
Breaking Biology Technology:Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Emerson Resources Forges Strategic Partnership with Bio Research 2Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 2Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas 3
...ogress of Phase I Programme With Oral Iclaprim, "R...ctronic Submission of First Module... December 12 Arpida Ltd,(SWX: ARPN) announced tod...in the Phase II clinical study with intravenous ic...onia (HAP) / ventilator-associated pneumonia,(VAP)...
...KLAND, Calif., Dec. 12 LUMEDX Corporation, the ma...scular information and imaging,solutions, introduc...,cardiology software that translates complex data ...ble, actionable information. CardioManager,s,perfo...users with a,high-level view of data and the abili...
... AMES, Iowa Fuel-cell cars are reaching commercia...ociety, but despite their promise, even scientists... central component the proton exchange membrane ...at the U.S. Department of Energys Ames Laboratory ...lanation to date for the membranes structure and h...
Other Biology Technology:First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 2First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 3First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 4First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 5New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance 2Ames Laboratory researchers solve fuel-cell membrane structure conundrum 2
(Date:11/4/2009)...stCall/ -- BIO-key International, Inc. (OTC Bullet...c identification software is showcasing donor and ...ence being held at the New Orleans Convention Cent...ands-on product demonstrations of its state-of-the..., at 5 PM on Monday, October 26, Peter Lux, manage...
(Date:11/4/2009)...ncoe Software, Inc., the commercial arm of the Ope...//openmicroscopy.org ), is proud to announce its ...ology,s exciting new project titled "The Cell: An ...stimulus grant through the National Institutes of ...t of the American Reinvestment and Recovery Act, t...
(Date:11/3/2009)...ublished in a recent issue of HortTechnology , sc...he effects of covering orchard floors with reflect...ght distribution, orchard temperature, and profita...day and Solarmate films installed 5 weeks before c...ples. The research showed that the use of both fil...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2Townhall Comes to Washington 3A FRC Action to Host Congressional Forum on Health Care 57410 1Townhall Comes to Washington 3A FRC Action to Host Congressional Forum on Health Care 57410 2AAHSA Statement on Senate Finance Committees Health Reform Bill 57406 1AAHSA Statement on Senate Finance Committees Health Reform Bill 57406 2Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 1Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 2
... Purdue University and the University of Californi... may be more effective at cleansing itself of smog...ught. , Scientists, including Joseph S. Francisco...pheric chemicals react with sunlight more effectiv...that "scrub" the air of smog. This group of chemic...
...irologists headed by Professor Hans-Georg Kräussli...h Professor Hanswalter Zentgraf, Division of Appli...zentrum (German Cancer Research Center, DKFZ), hav...iruses (HIV) for visual investigations without inh...s. , The labeling permits scientists to observe t...
...ularly deadly form of skin cancer very resistant t...Center & Research Institute and the University...apy that prompts the immune system to aid in the f...ne clinical trial because it is the first time tha... DNA in a gene therapy study in humans," said Rich...
Other Biology News:Atmosphere may cleanse itself better than previously thought 2Atmosphere may cleanse itself better than previously thought 3Atmosphere may cleanse itself better than previously thought 4Virologists make major step towards understanding the process of HIV infection 2Researchers test new therapy for advanced melanoma 2
...rose and SYBR Safe DNA Gel Stain combo offers thes...ame products separately Offers a safer and be...es risks to yourself, the environment and your ins...om 100 bp to >30 kb. UltraPure Agarose is a standa...
...s are E.Coli glycerol stocks contained in standard...cDNA clones with approximately 5,000 clones per pl... plate well, the corresponding subplate is screene...ve well(s). Cells from a positive well are then pl...
...per liter of urine will give a positive reaction f...cation: The Donors are of US origin and have been...IV-1 & 2, Syphilis and HIV-1 Antigen by currently ...-VITRO DIAGNOSTIC USE ONLY IN MANUFACTURING OR RES...
Smarter Fermentation System Controller for One Vessel from Major Science
Biology Products: